Last reviewed · How we verify
Other Parkinson's Disease treatments
Other Parkinson's Disease treatments is a Small molecule drug developed by Merck Sharp & Dohme LLC. It is currently in Phase 2 development.
At a glance
| Generic name | Other Parkinson's Disease treatments |
|---|---|
| Sponsor | Merck Sharp & Dohme LLC |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Deep Brain Stimulation Therapy in Movement Disorders (NA)
- DaxibotulinumtoxinA for Blepharospasm (PHASE2)
- Neurophysiological, Behavioral, and Cognitive Networks in Movement Disorders (NA)
- Montelukast in Parkinson Disease (PHASE2, PHASE3)
- Motor and Cognitive Exercise in Parkinson's Disease. (NA)
- Etiology-Phenotype-Outcome Pathway Study on Freezing of Gait (FOG)
- Efficacy of a Breathwork Practice (SKY) on Well-Being of Individuals With Parkinson's Disease (iPD) and Care Partners (NA)
- Repetitive Transcranial Magnetic Stimulation for Musculoskeletal Pain in Patients With Parkinson's Disease (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Other Parkinson's Disease treatments CI brief — competitive landscape report
- Other Parkinson's Disease treatments updates RSS · CI watch RSS
- Merck Sharp & Dohme LLC portfolio CI
Frequently asked questions about Other Parkinson's Disease treatments
What is Other Parkinson's Disease treatments?
Other Parkinson's Disease treatments is a Small molecule drug developed by Merck Sharp & Dohme LLC.
Who makes Other Parkinson's Disease treatments?
Other Parkinson's Disease treatments is developed by Merck Sharp & Dohme LLC (see full Merck Sharp & Dohme LLC pipeline at /company/merck).
What development phase is Other Parkinson's Disease treatments in?
Other Parkinson's Disease treatments is in Phase 2.